Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 5 | 2021 | 32 | 3.100 |
Why?
|
| Obesity, Morbid | 4 | 2021 | 71 | 2.060 |
Why?
|
| Gastrectomy | 3 | 2021 | 67 | 1.600 |
Why?
|
| Bariatric Surgery | 3 | 2020 | 25 | 1.470 |
Why?
|
| Phentermine | 2 | 2019 | 7 | 1.350 |
Why?
|
| Weight Loss | 7 | 2021 | 465 | 1.210 |
Why?
|
| Obesity | 8 | 2021 | 1158 | 1.140 |
Why?
|
| Delivery of Health Care | 2 | 2016 | 159 | 0.930 |
Why?
|
| Food Supply | 2 | 2014 | 67 | 0.840 |
Why?
|
| Diet | 3 | 2020 | 385 | 0.840 |
Why?
|
| Hernia, Hiatal | 1 | 2020 | 1 | 0.740 |
Why?
|
| Electronic Health Records | 5 | 2020 | 159 | 0.740 |
Why?
|
| Body Mass Index | 2 | 2021 | 916 | 0.690 |
Why?
|
| Appetite Depressants | 1 | 2019 | 6 | 0.680 |
Why?
|
| Anti-Obesity Agents | 1 | 2019 | 6 | 0.670 |
Why?
|
| Body Weight | 2 | 2021 | 306 | 0.640 |
Why?
|
| Adolescent | 8 | 2021 | 3511 | 0.620 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 409 | 0.590 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 42 | 0.570 |
Why?
|
| Mental Health | 1 | 2017 | 115 | 0.540 |
Why?
|
| Health Policy | 2 | 2014 | 82 | 0.540 |
Why?
|
| Humans | 23 | 2021 | 31836 | 0.540 |
Why?
|
| Gastroplasty | 1 | 2015 | 11 | 0.520 |
Why?
|
| United States | 7 | 2019 | 3925 | 0.500 |
Why?
|
| Government Regulation | 2 | 2013 | 29 | 0.500 |
Why?
|
| Taxes | 1 | 2014 | 4 | 0.500 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 12 | 0.490 |
Why?
|
| Beverages | 1 | 2014 | 19 | 0.490 |
Why?
|
| Postoperative Complications | 1 | 2019 | 779 | 0.480 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 1122 | 0.480 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 165 | 0.470 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 242 | 0.460 |
Why?
|
| Female | 16 | 2021 | 19859 | 0.460 |
Why?
|
| Male | 15 | 2021 | 19091 | 0.450 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 54 | 0.440 |
Why?
|
| Adult | 8 | 2021 | 9327 | 0.430 |
Why?
|
| Young Adult | 5 | 2021 | 2603 | 0.420 |
Why?
|
| Food Industry | 1 | 2011 | 9 | 0.400 |
Why?
|
| Nutrition Policy | 1 | 2011 | 35 | 0.390 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 1169 | 0.390 |
Why?
|
| Health Behavior | 1 | 2013 | 231 | 0.390 |
Why?
|
| Health Promotion | 1 | 2013 | 246 | 0.370 |
Why?
|
| Retrospective Studies | 4 | 2020 | 3488 | 0.360 |
Why?
|
| Cohort Studies | 3 | 2019 | 1824 | 0.350 |
Why?
|
| Hispanic Americans | 1 | 2016 | 942 | 0.350 |
Why?
|
| African Americans | 1 | 2016 | 1428 | 0.320 |
Why?
|
| Income | 2 | 2020 | 61 | 0.320 |
Why?
|
| Middle Aged | 9 | 2021 | 11824 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1424 | 0.320 |
Why?
|
| Treatment Outcome | 4 | 2021 | 3294 | 0.310 |
Why?
|
| Child, Preschool | 3 | 2020 | 1259 | 0.300 |
Why?
|
| Interleukin-6 | 2 | 2019 | 251 | 0.290 |
Why?
|
| Mobility Limitation | 2 | 2019 | 219 | 0.280 |
Why?
|
| Hypertension | 1 | 2013 | 956 | 0.280 |
Why?
|
| Infant | 2 | 2020 | 1055 | 0.280 |
Why?
|
| Databases, Factual | 2 | 2019 | 349 | 0.270 |
Why?
|
| Ethnic Groups | 2 | 2020 | 476 | 0.260 |
Why?
|
| North Carolina | 2 | 2020 | 1514 | 0.260 |
Why?
|
| Child | 3 | 2020 | 2425 | 0.250 |
Why?
|
| Prevalence | 2 | 2016 | 979 | 0.210 |
Why?
|
| Losartan | 2 | 2019 | 64 | 0.210 |
Why?
|
| Insurance Claim Review | 1 | 2021 | 27 | 0.190 |
Why?
|
| Risk Factors | 2 | 2019 | 3851 | 0.190 |
Why?
|
| Postoperative Period | 1 | 2021 | 97 | 0.190 |
Why?
|
| Censuses | 1 | 2020 | 10 | 0.180 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 32 | 0.180 |
Why?
|
| Physical Therapy Modalities | 1 | 2020 | 64 | 0.170 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 65 | 0.170 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 56 | 0.170 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2018 | 5 | 0.160 |
Why?
|
| Reoperation | 1 | 2019 | 226 | 0.160 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2020 | 89 | 0.160 |
Why?
|
| Insurance, Health | 1 | 2019 | 95 | 0.160 |
Why?
|
| Cause of Death | 1 | 2019 | 238 | 0.150 |
Why?
|
| Mortality | 1 | 2019 | 124 | 0.150 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 771 | 0.150 |
Why?
|
| Health Expenditures | 1 | 2017 | 66 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2017 | 75 | 0.140 |
Why?
|
| Propensity Score | 1 | 2015 | 39 | 0.130 |
Why?
|
| Drug Costs | 1 | 2015 | 47 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2016 | 147 | 0.130 |
Why?
|
| Quality of Life | 1 | 2021 | 924 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2019 | 632 | 0.120 |
Why?
|
| Patient Selection | 1 | 2016 | 276 | 0.120 |
Why?
|
| Health Care Costs | 1 | 2015 | 117 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2271 | 0.120 |
Why?
|
| Risk Assessment | 1 | 2019 | 1431 | 0.110 |
Why?
|
| Time Factors | 1 | 2019 | 2146 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2015 | 171 | 0.110 |
Why?
|
| Inflammation | 1 | 2017 | 540 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 136 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 168 | 0.110 |
Why?
|
| Hospitalization | 1 | 2015 | 463 | 0.100 |
Why?
|
| Personal Autonomy | 1 | 2011 | 7 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 471 | 0.100 |
Why?
|
| Incidence | 1 | 2014 | 1192 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2019 | 523 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 537 | 0.070 |
Why?
|
| Aged | 4 | 2020 | 10288 | 0.060 |
Why?
|
| Group Processes | 1 | 2020 | 15 | 0.040 |
Why?
|
| Family | 1 | 2020 | 117 | 0.040 |
Why?
|
| Patient Participation | 1 | 2020 | 80 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2020 | 166 | 0.040 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 29 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1527 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 351 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 3988 | 0.020 |
Why?
|